[1] VADUGANATHAN M, MENSAH GA, TURCO JV, et al.The Global Burden of Cardiovascular Diseases and Risk: a Compass for Future Health[J]. J Am Coll Cardiol, 2022, 80(25): 2361-2371. [2] ALGOET M, JANSSENS S, HIMMELREICH U, et al.Myocardial Ischemia-Reperfusion Injury and the Influence of Inflammation[J]. Trends Cardiovasc Med, 2023, 33(6): 357-366. [3] LI Z, LIN C, CAI X, et al.Anti-Inflammatory Therapies Were Associated with Reduced Risk of Myocardial Infarction in Patients with Established Cardiovascular Disease or High Cardiovascular Risks: a Systematic Review and Meta-Analysis of Randomized Controlled Trials[J]. Atherosclerosis, 2023, 379: 117181. [4] KALAYC B, HAMAMC O, LU AC, et al.Hematological Indices May Predict Oxidative Stress in Patients with ST-Segment Elevation Myocardial Infarction[J]. Turk Kardiyol Dern Ars, 2023, 51(3): 196-201. [5] WAL P, AZIZ N, SINGH YK, et al.Myocardial Infarction as a Consequence of Mitochondrial Dysfunction[J]. Curr Cardiol Rev, 2023, 19(6): 23-30. [6] FRANTZ S, HUNDERTMARK MJ, SCHULZ-MENGER J, et al.Left Ventricular Remodelling Post-Myocardial Infarction: Pathophysiology, Imaging, and Novel Therapies[J]. Eur Heart J, 2022, 43(27): 2549-2561. [7] SALEH M, AMBROSE JA.Understanding Myocardial Infarction[J]. F1000Research, 2018, 7: F1000. [8] LIN L, LIU JX, ZHANG Y, et al.A PK/PD Data Processing Study on Chinese Formulation of Shuang-Shen-Tong-Guan Prescription[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology(世界科学技术-中医药现代化), 2012, 14(3): 1583-1589. [9] HUANG S, LIU JX, LI L, et al.Effects of Shuangshen Tongguan Formula on the Rat Model of Coronary Heart Disease with Syndrome of Blood Stasis Due to Qi Deficiency[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2017, 32(7): 3109-3116. [10] DONG JF, MA XC.Observation on Shuangshen Ningxin Granules in Treating Stable Angina Pectoris of Qi-Deficiency Blood Stasis Pattern[J]. Western Journal of Traditional Chinese Medicine(西部中医药), 2019, 32(1): 70-73. [11] LI L, MENG HX, XIN GJ, et al.Effect of Shuangshen Ningxin Capsules on Cardiac Function and Hemodynamics in Rats with Coronary Microvascular Dysfunction[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2021, 27(22): 41-50. [12] ZHAO YW, FU JH, LI L, et al.Effect of Shuangshen Ningxin Capsule in Alleviating Myocardial Ischemia/Reperfusion Injury in Rats by Regulating Mitochondrial ATP-Sensitive Potassium Channel[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2020, 26(13): 104-110. [13] XIN GJ.Protective Effects of Shuangshen Ningxin Capsule on MIRI via the Regulation of Mitochondrial Quality Control[D]. Beijing: China Academy of Chinese Medical Sciences, 2024. [14] LI LM.Study on the Mechanism of Shuangshen Ningxin Capsule Regulating NLRP3 Inflammasome against Myocardial Ischemia/Reperfusion Injury[D]. Beijing: China Academy of Chinese Medical Sciences, 2023. [15] DING YM, GAO J, XING YM, et al.Establishment of a Mouse Myocardial Infarction Model and Systematic Evaluation[J]. Acta Laboratorium Animalis Scientia Sinica(中国实验动物学报), 2022, 30(7): 873-879. [16] WANG ZB, WU YJ, ZHANG YH, et al.Pharmacodynamic Effect of Compound Ginseng Buqi Granules on Myocardial Protection in Myocardial Failure Rats after Myocardial Infarction Based on the Theory of Yiqihuoxue[J]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), 2021, 37(3): 150-157. [17] MA L, ZHU BX, WU YY, et al.Effect of Yiqi Huoxue Huayu Decoction on Myocardial Energy Shuttle, Ventricular Remodeling and Heart Function in Patients with Chronic Heart Failure[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2021, 30(7): 685-688, 724. [18] QIU SL, ZHOU QI, SHANG JJ.Effects of Supplementing Qi and Activating Blood Circulation on the Risk of Venous Thromboembilism in Patients with Acute Myocardial Infarction[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease(中西医结合心脑血管病杂志), 2020, 18(19): 3263-3265. [19] LAN HQ, TANG HQ, HUANG CH, et al.Advances in the Treatment of Coronary Heart Disease with Qi-Deficiency and Blood-Stasis Syndrome by Invigorating Qi and Activating Blood Prescription[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2018, 20(9): 107-110. [20] HILGENDORF I, FRANTZ S, FRANGOGIANNIS NG.Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities[J]. Circ Res, 2024, 134(12): 1718-1751. [21] MEHDIZADEH M, AGUILAR M, THORIN E, et al.The Role of Cellular Senescence in Cardiac Disease: Basic Biology and Clinical Relevance[J]. Nat Rev Cardiol, 2022, 19(4): 250-264. [22] BALARAMAN AK, ALTAMIMI ASA, BABU MA, et al.The Interplay of Senescence and MMPs in Myocardial Infarction: Implications for Cardiac Aging and Therapeutics[J]. Biogerontology, 2025, 26(1): 46. [23] NAIR V, DEMITRI C, THANKAM FG.Competitive Signaling and Cellular Communications in Myocardial Infarction Response[J]. Mol Biol Rep, 2025, 52(1): 129. [24] CHUNHACHA P, PINKAEW D, SINTHUJAROEN P, et al.Fortilin Inhibits p53, Halts Cardiomyocyte Apoptosis, and Protects the Heart against Heart Failure[J]. Cell Death Discov, 2021, 7(1): 310. [25] LIU X, BURKE RM, LIGHTHOUSE JK, et al.p53 Regulates the Extent of Fibroblast Proliferation and Fibrosis in Left Ventricle Pressure Overload[J]. Circ Res, 2023, 133(3): 271-287. |